In the course of a screening program for inhibitors of epidermal growth factor (EGF)-induced phosphatidylinositol turnover in humanepidermoid carcinoma cell line A431, we discovered two novel compoundsof the piericidin family from the culture broth and mycelia of a Streptomyces strain MJ288-OF3.
spectrometric analyses, the molecular formulas of piericidin B5 and B5 N-oxide were determined to be C27H41NO4 (MW 443) and C27H41NO5 (MW 459), respectively. Piericidin B5 and B5 TV-oxide inhibited phosphatidylinositol turnover of A431 cells with IC5Os of 10.0/jg/ml and l.l^g/ml, respectively.
Phosphatidylinositol turnover is considered to be correlated with transformation by some types of oncogenes1 '2) and cellular response to growth factors such as EGF3) and platelet-derived growth factor4). Enzymatic breakdown of phosphatidylinositol 4,5-bisphosphate by phospholipase C generates inositol 1 ,4,5-triphosphate and 1,2-diacylglycerol. These products both act as intracellular second messengers5), the former mobilizing Ca2 + from intracellular stores and the latter stimulating protein kinase C activity. Wehave screened inhibitors of phosphatidylinositol turnover from microbial secondary metabolites, and previously isolated psi-tectorigenin6), inostamycin7) and piericidin Bx iV-oxide8). Piericidins are insecticidal substances found from Streptomyces mobaraensis9' 10) and Streptomyces pactum1^. They are systematically named piericidins An, Bn, Cn and Dn (n= 1, 2, 3, 4)12). We have isolated novel and potent inhibitors of phosphatidylinositol turnover produced by a Streptomyces strain and named them piericidin B5 and B5 TV-oxide because of their structural relationship to the piericidin B group.
Materials and Methods

Materials
The A431 cell line was a gift from Prof. S. Kawai, Institute of Medical Science, University of Tokyo. Piericidin Bx was kindly supplied by Dr. S. Yoshida, the Institute of Physical and Chemical Research, Wako. Afyo-[3H]inositol was purchased from DuPont-New England Nuclear.
In Situ Phosphatidylinositol
Turnover Assay The phosphatidylinositol turnover assay was carried out as described previously6>7). In brief, A431 Then, the inhibitor and EGF(400ng/ml) were added and the incubation was continued at 37°C for 60 minutes. The cells were washed with 1.0ml of 10% TCAcontaining 0.01 m sodium pyrophosphate and the acid-insoluble fraction was solubilized using 1.0 ml of 0.25 n NaOH.The radioactivity of labeled phosphoinositides was measured by liquid scintillation counting.
Fermentation
The Streptomyces strain MJ288-OF3was inoculated into 1 10ml of seed medium consisting with 4.0% sucrose, 2.5% soybean meal, 0.25% NaCl, 0.32% CaCO3, 0.0005% CuSO4/5H2O, 0.0005% MnCl2 -4H2O and 0.0005% ZnSO4-5H2O (adjusted to pH 7.4 before sterilization). The seed culture was incubated for 3 days at 28°C on a rotary shaker (180rpm). Two ml of the culture was then transferred to 110ml of fermentation mediumwhose composition was equivalent to that of the seed medium. The fermentation was carried out for 4 days at 28°C on a rotary shaker (180rpm).
Isolation
The fermentation broth (12 liters) was filtered, and the mycelia were extracted with acetone (1 liter).
After removal of the acetone, the extract was combined with the filtrate (10.8 liters). The mixture was extracted with EtOAc (14 liters) and the EtOAc layer was dried over anhydrous Na2SO4. The EtOAc extract was then concentrated in vacuo to give an oily matter (4.65 g), which was subjected to a silica gel column chromatography (200 ml; column I).
Piericidin B5 was isolated as follows. The fractions containing piericidin B5, eluted with CHC13from the column I, were concentrated in vacuo to yield 716.0mg of oily material. The oily material was further applied to a silica gel column (30 ml). The column was successively washed with toluene, toluene -EtOAc (50: 1) and toluene-EtOAc (30: 1), and piericidin B5 was eluted with toluene-EtOAc (10: 1). After evaporation to dryness, the residue (340.5 mg) was chromatographed on Sephadex LH-20 (150ml) with EtOAc. The combined active fraction (228.6 mg) was partitioned in a solvent system w-hexane -CH3CN (1 : 1) by centrifugal partition chromatography (CPC, Sanki Engineering Co. Ltd.), in which the lower portion was stationary. The fractions containing piericidin B5 were collected and further purified with w-hexane-CH3CN-28%NH4OH(125 : 125 : 1) in CPC. Thus, 6.3mg of piericidin B5 was obtained.
Piericidin B5 TV-oxide was isolated as follows. The fractions containing piericidin B5 TV-oxide eluted with CHC13-MeOH(10 : 1) from column I were concentrated in vacuo to give 976.4mg of oily material. It was rechromatographed on a silica gel column (40ml) and eluted with CHCl3 -MeOH(30 : 1). After evaporation to dryness, the residue (523.0 mg) was partitioned in the solvent system CHC13-MeOH-H2O (5 : 6 : 4) in CPC. The combined active fraction (496.8 mg) was further purified by preparative HPLCusing a reverse phase silica gel column (Nucleosil 5C18 30 x 250mm) with a solvent system of 85% MeOH.The eluate was concentrated to yield 39.9 mg of purified piericidin B5 TV-oxide. Reduction of Piericidin B5 TV-Oxide to Piericidin B5 APR. 1993 A mixture of piericidin B5 TV-oxide (17.1 mg) and zinc powder (174.8mg) in CH3COOH(1.5ml) was stirred at 40°C for 2hours. The reaction mixture was diluted with distilled water (50ml) and extracted with EtOAc (25 ml x 2 times). The organic layer was successively washed with saturated NaHCO3(50 ml) and water (25 ml x 2 times), and dried over anhydrous Na2SO4.The organic extract was concentrated in vacuo and subjected to the CPCsystem with a solvent system of «-hexane-CH3CN(1 : 1). After concentration to dryness, 9.9mg of the reduced material was obtained. The reduced substance was identical to piericidin B5 by FAB-MSand XH NMRanalyses.
Results and Discussion
Wehave found two novel phosphatidylinositol turnover inhibitors, piericidin B5 and B5 iV-oxide, produced by a Streptomyces strain MJ288-OF3. Morphological and physiological studies indicated that the strain is similar to Streptomyces aburaviensis. The producing strain also gave piericidin Bx and Bl TV-oxide previously. with piericidin B1 N-oxide8) by UV, FAB-MS, XH and 13C NMRanalyses. Further, we chemically reduced piericidin B5 TV-oxide to piericidin B5 and confirmed that the reduced substance was identical to piericidin B5 by FAB-MS and *H NMRanalyses. Absolute configurations of C-9 and C-10 in both piericidin B5 and B5 TV-oxide were determined to be S-S since the optical rotations of piericidin B5 (-12.5°) and B5 TV-oxide (-8.0°) are similar to those of piericidin Bt (-6.5°)1O) and Bx TV-oxide
respectively. Thus, we have concluded that the structures of piericidin B5 and B5 TV-oxide are as shown in Fig. 1 . Piericidin B5 and B5 TV-oxide inhibited EGFstimulated
[3H]inositol incorporation into phospholipids with IC5Os of 10.0/jg/ml and 1.1 /ig/ml, respectively, in the A431 cells assay system. As shown in Table 3 , piericidin B5 TV-oxide showed antimicrobial activity against Gram-positive and part of Gram-negative bacteria and fungi, although piericidin B5 did not. In the case of piericidin Bl5 again only the iV-oxide shows antimicrobial activity8). 
